In a retrospective study, patients with neovascular age-related macular degeneration treated with anti-VEGF injections experienced decreased visual acuity from baseline and decreased number of injections at 4 years’ follow-up, according to a study.
“In this large real-world study looking at 98,821 eyes from 79,885 patients, with up to 4-year follow-up, both [visual acuity] and injection frequency declined over time. The study highlights the treatment burden experienced by the patients with [neovascular] AMD and need for durable treatment options to have better vision acuity
Uncategorized